Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06375694 · ClinicalTrials.gov registry record · NA

Probiotic Effect on Dietary Nitrate to Plasma Nitrite Production ( OPEDNPN )

A NA study of Hypertension and Diabetes, sponsored by Wake Forest University.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06375694 is a NA study of Hypertension and Diabetes that is actively recruiting participants, run by Wake Forest University. The registered enrollment target is 20 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06375694, a NA study of Hypertension and Diabetes, is actively recruiting participants, sponsored by Wake Forest University.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Nitric Oxide (NO) is an important molecule that is produced naturally in the body and that helps maintain healthy blood flow. Low availability of NO contributes to many diseases while administration of NO is therapeutic. In addition to being made naturally in the body, NO can be obtained through the diet via the Nitrate-Nitrite-NO cycle. Nitrate, which is abundant in green leafy vegetables and beetroot juice, is partially converted to nitrite by oral bacteria. The nitrate and nitrite are taken up into the blood and nitrite is converted into NO. Remaining nitrate in the blood is taken back up into the mouth by salivary glands and the cycle continues. Emerging studies suggest that the Nitrate-Nitrite-NO cycle may contribute to cardiovascular health. In addition, there have been many studies where dietary nitrate is given to increase NO and treat various conditions. The current study rests on the premise that the quality of the oral microbiome plays a major role in the Nitrate-Nitrite-NO cycle and hence cardiovascular health and the efficacy of dietary nitrate interventions. Investigators have begun to identify oral bacterial species that are effective nitrite producers as well as though that are nitrite depleters (those that interfere with nitrite production from nitrate). In laboratory experiments, certain bacterial species have been shown to block nitrate to nitrite conversion by other oral bacteria. These nitrite depleting species are found in a commercially available oral probiotic designed to improve oral health. The purpose of this study is to examine if use of the probiotic negatively affects the Nitrate-Nitrite-NO cycle. Nitrate to Nitrite conversion will be assessed by measuring plasma levels of nitrite before and after consumption of nitrate-rich beetroot juice. Dietary nitrate to plasma nitrite conversion will assessed at baseline and after one week of consumption of the probiotic or a placebo (follow-up). The primary hypothesis of this study is that par

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Herbiotics Oral + Ent Probiotic

Study Locations (1)

North Carolina

  • Wake Forest University - Winston-Salem

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-06-01
Est. Completion 2025-05
Phase NA

Sponsor

Wake Forest University

100 total trials

What the Registry Record Tells You About NCT06375694

The ClinicalTrials.gov registry entry for NCT06375694 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06375694 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06375694 about?

NCT06375694 is a clinical study titled "Probiotic Effect on Dietary Nitrate to Plasma Nitrite Production ( OPEDNPN )". Nitric Oxide (NO) is an important molecule that is produced naturally in the body and that helps maintain healthy blood flow. Low availability of NO contributes to many diseases while administration of NO is therapeutic. In addition to being made naturally in the body, NO can be obtained through th...

What is the current status of trial NCT06375694?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-06-01. Estimated completion is 2025-05.

What conditions does trial NCT06375694 study?

This clinical trial studies the following conditions: Hypertension, Diabetes, Cardiovascular Diseases.

What interventions are being tested in trial NCT06375694?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Herbiotics Oral + Ent Probiotic (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06375694?

This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06375694 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.